These findings also corroborate a prior study [46] that linked serum-derived EVs to the production of type 1 IFNs through the STING pathway in SLE patients, supporting the overall notion that EVs are contributors to the pathogenesis of autoimmune diseases like DM [47]. This evidence concerns the gene STING1 and dermatomyositis.